SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-007462
Filing Date
2018-05-18
Accepted
2018-05-18 17:01:17
Documents
52
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 574757
2 ex31-1.htm EX-31.1 19235
3 ex31-2.htm EX-31.2 19327
4 ex32-1.htm EX-32.1 7213
5 ex32-2.htm EX-32.2 7217
  Complete submission text file 0001493152-18-007462.txt   3166682

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE mrna-20180331.xml EX-101.INS 423251
7 XBRL SCHEMA FILE mrna-20180331.xsd EX-101.SCH 44712
8 XBRL CALCULATION FILE mrna-20180331_cal.xml EX-101.CAL 34848
9 XBRL DEFINITION FILE mrna-20180331_def.xml EX-101.DEF 212216
10 XBRL LABEL FILE mrna-20180331_lab.xml EX-101.LAB 298176
11 XBRL PRESENTATION FILE mrna-20180331_pre.xml EX-101.PRE 241795
Mailing Address 17870 CASTLETON STREET SUITE 250 CITY OF INDUSTRY CA 91748
Business Address 17870 CASTLETON STREET SUITE 250 CITY OF INDUSTRY CA 91748 4259083600
Marina Biotech, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 18847467
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1